Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients' lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme's commercially-validated solution has positively impacted more than 400,000 patient lives via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Halozyme's proprietary enzyme rHuPH20 forms the basis of the ENHANZE® technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly, Bristol-Myers Squibb, Alexion and argenx. Halozyme derives revenues from these collaborations in the form of milestones and royalties as the company's partners make progress developing and commercializing their products being developed with ENHANZE®.
We are a diverse team, who are committed to bringing therapies and results to patients. It's not enough to be qualified and experienced at what you do, we are looking for people who believe in our mission and match our values.
We are building a company where people can pursue their career goals in a supportive and collaborative team environment. Visit www.halozyme.com/careers for more details.
We are Halozyme.
|
|
|
51-200 employees
View all Halozyme Therapeutics, Inc. employees
|
|
Biotechnology
|
|
11388 Sorrento Valley Road, CA, San Diego 92121, US
|
|
Biotechnology, Hyaluronidase, Rhuph20, Subcutaneous Biologics, Biotechnology
|
The decision makers in Halozyme Therapeutics, Inc. are Amy Fox, Athena Countouriotis, Christopher Bryant, etc. Click to Find Halozyme Therapeutics, Inc. decision makers emails.
You can reach Halozyme Therapeutics through their official website's contact page. They provide a contact form for general inquiries, and you can also find relevant email addresses and phone numbers for specific departments to ensure your questions are directed appropriately.
Halozyme Therapeutics does not publicly provide a detailed staff directory. However, you can find key leadership information and department contacts on their official website, which can help you connect with the right individuals for your inquiries.
Halozyme Therapeutics primarily supports the biotechnology and pharmaceutical industries. Their innovative solutions focus on enhancing drug delivery systems, particularly through subcutaneous biologics, which improve patient experiences and treatment outcomes across various therapeutic areas.
Yes, information about Halozyme's partnerships and collaborations can be found on their website. They often highlight key collaborations that enhance their drug development capabilities and expand their impact in the biopharmaceutical field.
To inquire about job opportunities at Halozyme Therapeutics, visit their careers page on the official website. There, you can find current job openings and submit your application or inquiry directly through the provided channels.
Halozyme's hyaluronidase technology, specifically rHuPH20, enhances the absorption of biologics when administered subcutaneously. This innovative approach allows for faster and more efficient delivery of medications, improving patient comfort and adherence to treatment regimens.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.